For decades, antibiotics have been viewed as weapons against bacteria. But what if some of them could also help repair the brain? A fascinating new study from researchers at the University of Kentucky and the University of California San Francisco suggests that a class of antibiotics called aminoglycosides may hold promise for treating a rare and devastating form of dementia: Frontotemporal Dementia (FTD).
Unlike Alzheimer’s disease, FTD often strikes earlier — commonly between the ages of 40 and 65 — gradually affecting: - Personality - Behavior - Speech and language - Memory and executive function The most intriguing part? Some patients with FTD carry a genetic mutation that blocks the production of a crucial brain protein called progranulin, a protein essential for neuronal survival and regulation of inflammation. Researchers discovered that two aminoglycoside antibiotics —…
